Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancerYifan Feng, Tiantai Zhang, Chengjuan Chen et al.|Acta Pharmaceutica Sinica B|2024Cited by 29
Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018Ran Zhou, Weihong Zheng, Meini Zhang et al.|Frontiers in Neurology|2021Cited by 13
Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: Follow-up studyJiarui Yao, WU Wei-ping, Dehui Huang et al.|Journal of the Neurological Sciences|2014Cited by 11
[Sporadic Creutzfeldt-Jakob Disease With Slow Progression:Report of One Case].Jiahua Zhao, Dehui Huang, Lei Wu et al.|PubMed|2023Cited by 0